T Mary Szela
Affiliations
- Ceo And President at Trisalus Life Sciences Inc. (TLSI), 2024-09-13
- at Omega Therapeutics Inc. (OMGA), 2024-06-21
- at Kura Oncology Inc. (KURA), 2024-06-07
- Director at Prometheus Biosciences Inc. (RXDX), 2023-06-16
- Director at Coherus Biosciences Inc. (CHRS), 2021-01-13
- Director at Alimera Sciences Inc (ALIM), 2020-06-22
- Chief Executive Officer at Novelion Therapeutics Inc. (NVLN), 2017-05-11
- Chief Executive Officer at Aegerion Pharmaceuticals Inc. (AEGR), 2016-12-01
- Director at Receptos Inc. (RCPT), 2015-08-27
- Senior Vice President at Abbott Laboratories (ABT), 2011-12-16
Insider Trading: Purchases See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
TLSI | $5.00 | 6,000 | 384,677 | 2024-09-13 | Filing | ||
TLSI | $4.83 | 1,295 | 378,677 | 2024-09-13 | Filing | ||
TLSI | $5.20 | 7,520 | 377,382 | 2024-09-12 | Filing | ||
TLSI | $4.97 | 5,000 | 369,862 | 2024-09-10 | Filing |
Insider Trading: Sales See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
CHRS | $17.58 | 54,997 | Director | 0 | 2020-06-22 | Filing | |
ABT | $54.46 | 500 | Officer | 119,342 | 2011-12-14 | Filing | |
ABT | $54.45 | 2,781 | Officer | 119,842 | 2011-12-14 | Filing | |
ABT | $54.44 | 3,200 | Officer | 122,623 | 2011-12-14 | Filing | |
ABT | $54.43 | 2,700 | Officer | 125,823 | 2011-12-14 | Filing |